Lung Tumor Gene Test Predicts Surgery Outcomes

January 28th, 2012    Posted by: admin

An assay which measures the activity of 14 genes in lung cancer tumors can accurately predict who will respond well to surgery and who will probably die within five years, researchers from the University of California, San Francisco, reported in The Lancet…
Lees meer..


Genetic Mutation That Triggers Pancreatic Cancer Identified

January 28th, 2012    Posted by: admin

Scientists at The University of Texas MD Anderson Cancer Center have identified a self-perpetuating “loop” of molecular activity that fuels pancreatic cancer by linking two signature characteristics of the disease – Kras, a gene that serves as a molecular on-off switch, but gets stuck on the “on” position when mutated, and NF-κB, a protein complex that controls activation of genes…
Lees meer..


Method Discovered By Researchers To Unravel Malaria’s Genetic Secrets

January 28th, 2012    Posted by: admin

The parasite that causes malaria is a genetic outlier, which has prevented scientists from discovering the functions of most of its genes. Researchers at National Jewish Health and Yale University School of Medicine have devised a technique to overcome the genetic oddity of Plasmodium falciparum, the major cause of human malaria…
Lees meer..


Too Much Fructose Sweetener Tied to Heart Risks in Teens

January 28th, 2012    Posted by: admin

FRIDAY, Jan. 27 — Teens who consume large amounts of the food and beverage sweetener fructose show evidence of cardiovascular disease and diabetes risk in their blood, a new study finds.
Fructose is found in fruits, while a form of fructose –…



Lees meer..


Discrimination Seems to Harm Health Regardless of Race

January 28th, 2012    Posted by: admin

FRIDAY, Jan. 27 — Discrimination can be a threat to health, according to a new study that included both blacks and whites.
The analysis of 2004 data from the ongoing U.S. Behavioral Risk Factor Surveillance System project found that about 18…



Lees meer..


Bydureon Approved for Type 2 Diabetes

January 28th, 2012    Posted by: admin

FRIDAY, Jan. 27 — Bydureon (exenatide extended release), Amylin Pharmaceuticals’ long-acting version of the diabetes drug Byetta, has been approved by the U.S. Food and Drug Administration.
The once-weekly injection will include a label warning…



Lees meer..


Off-Campus Party Hosts Drank Most in College Survey

January 28th, 2012    Posted by: admin

FRIDAY, Jan. 27 — College students who host off-campus parties drink more than their guests, according to a study, which also found that hosts tend to be males, members of a fraternity, in their sophomore year or higher and have more money to spend…



Lees meer..


Students Report Playing Dangerous ‘Choking Game’

January 28th, 2012    Posted by: admin

FRIDAY, Jan. 27 — The “choking game” has been played by nearly one in seven students who were surveyed at a Texas university, a new study finds.
This so-called ‘game’ is played individually or in groups and involves deliberately cutting off blood…



Lees meer..


Tropical Trip OK for Most With Crohn’s, Colitis

January 28th, 2012    Posted by: admin

FRIDAY, Jan. 27 — Among people with inflammatory bowel disease — a chronic intestinal disorder that commonly takes the form of Crohn’s disease or ulcerative colitis — those who travel to developing nations or tropical locales do not have a…



Lees meer..


Inlyta Approved for Advanced Kidney Cancer

January 28th, 2012    Posted by: admin

FRIDAY, Jan. 27 — Inlyta (axitinib) has been approved by the U.S. Food and Drug Administration to treat advanced renal cell carcinoma in people who haven’t responded to another drug.
Renal cell carcinoma is a form of kidney cancer that begins in…



Lees meer..